SCHEMBL7993389

SCHEMBL7993389

Fc1ccc2c(C3CNCCN3)csc2c1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
HTR2A P28223 7/20 0.36
HTR2C P28335 5/20 0.36
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
KCNH2 Q12809 4/20 0.32
DRD2 P14416 3/20 0.32
TP53 P04637 3/20 0.32
THRB P10828 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
AVPR2 P30518 1/20 0.32
AVPR1A P37288 1/20 0.32
AVPR1B P47901 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7997129 0.83 HTR2A (0.36) HTR2AHTR2CCHRNB2CHRNA4KCNH2
Hydrochloric Acid SCHEMBL2957745 0.81 HTR2C (0.39) HTR2AHTR2CCHRNB2CHRNB4CHRNA3
SCHEMBL7993430 0.81 SLC6A4 (0.40) MAPTDRD2CA1CA2
SCHEMBL22871575 0.79 CHRNB2 (0.47) MAPTLMNAALDH1A1POLBHTR2A
Hydrochloric Acid SCHEMBL28259402 0.78 CHRNB2 (0.46) MAPTLMNAALDH1A1POLBHTR2A
SCHEMBL7468044 0.77 SLC6A2 (0.44) MAPTLMNAALDH1A1POLBKCNH2
Hydrochloric Acid SCHEMBL1673605 0.75 SLC6A2 (0.43) HTR2CKCNH2
SCHEMBL4536065 0.75 CHRNB2 (0.42) HTR2AHTR2CCHRNB2CHRNB4CHRNA3
Hydrochloric Acid SCHEMBL4024027 0.74 CHRNB2 (0.41) HTR2AHTR2CCHRNB2CHRNB4CHRNA3
SCHEMBL694609 0.73 AVPR2 (0.40) MAPTLMNAALDH1A1POLBDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6284775-B1 PSYCHOLOGICAL DISORDERS AVENTIS PHARMACEUTICALS INC. 2001-09-04 US disclosed
EP-0511610-B1 Benzisothiazole- and benzisoxazole-3-carboxamides, a process for their preparation and their use as antipsychotic medicaments HOECHST ROUSSEL PHARMA (US) 1996-09-11 EP disclosed
US-5371087-A Antipsychotic, analgesics, anticonvulsant and anxiolytic agent HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-12-06 US disclosed
US-5229388-A 3-[4-(1-substituted-4-piperazinyl)butyl]-4-thiazolidinone and related compounds HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-07-20 US disclosed
EP-0511610-A1 Benzisothiazole- and benzisoxazole-3-carboxamides, a process for their preparation and their use as antipsychotic medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-11-04 EP disclosed
US-5143923-A Psychological disorders HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-09-01 US disclosed
US-5136037-A 3-(4-substituted-4-piperazinyl)butyl-4-thiazolidinone and related compounds HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-08-04 US disclosed
US-5037984-A Anticonvulsants; anxiolytic agents HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1991-08-06 US disclosed
US-4933453-A ANTIPSYCHOTIC, ANALGESIC, ANTICONVULSANT, AND ANXIOLYTIC AGENTS HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1990-06-12 US disclosed